|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/277 | (2006.01) |
| A61K 31/337 | (2013.01) | ||
| A61K 31/65 | (2006.01) | ||
| A61K 31/513 | (2013.01) | ||
| A61K 31/704 | (2006.01) | ||
| A61K 31/65 | (2013.01) | ||
| A61K 31/513 | (2006.01) | ||
| A61K 31/704 | (2013.01) | ||
| A61K 31/337 | (2006.01) | ||
| A61K 31/7068 | (2013.01) | ||
| A61K 31/7068 | (2006.01) | ||
| A61K 31/275 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 31/277 | (2013.01) | ||
| A61K 31/138 | (2013.01) | ||
| A61K 31/167 | (2013.01) | ||
| A61K 31/17 | (2013.01) | ||
| A61K 31/40 | (2013.01) | ||
| A61K 31/4045 | (2013.01) | ||
| A61K 31/4184 | (2013.01) | ||
| A61K 31/429 | (2013.01) | ||
| A61K 31/4965 | (2013.01) | ||
| A61K 31/5415 | (2013.01) | ||
| A61K 31/5513 | (2013.01) | ||
| A61K 31/567 | (2013.01) | ||
| A61K 31/585 | (2013.01) | ||
| A61P 1/04 | (2018.01) | ||
| A61P 1/16 | (2018.01) | ||
| A61P 1/18 | (2018.01) | ||
| A61P 13/08 | (2018.01) | ||
| A61P 15/00 | (2018.01) | ||
| A61P 25/00 | (2018.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/02 | (2018.01) | ||
| A61P 43/00 | (2018.01) |
| (11) | Number of the document | 3062790 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14859220.7 |
| Date of filing the European patent application | 2014-10-31 | |
| (97) | Date of publication of the European application | 2016-09-07 |
| (45) | Date of publication and mention of the grant of the patent | 2023-03-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/AU2014/001017 |
| Date | 2014-10-31 |
| (87) | Number | WO 2015/061832 |
| Date | 2015-05-07 |
| (30) | Number | Date | Country code |
| 2013904239 | 2013-11-01 | AU |
| (72) |
MORRIS, David Lawson , AU
POURGHOLAMI, Mohammad Hossein , AU
ASTON, Roger , AU
|
| (73) |
Pitney Pharmaceuticals Pty Limited ,
Suite 39
1 Freshwater Parade, Claremont, WA 6010,
AU
|
| (54) | PHARMACEUTICAL COMBINATIONS FOR THE TREATMENT OF CANCER |
| PHARMACEUTICAL COMBINATIONS FOR THE TREATMENT OF CANCER |